Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study

NCT00002146 is registered in ClinicalTrials.gov with Astra USA as lead sponsor.

NCT NCT00002146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
Lead sponsor
Astra USA
Phase
Phase 4
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections, hiv infections, hypocalcemia